Free
Free
- site check: one company or site per call, API without a key, MCP
- weekly alert for up to 10 companies
- 25 calls a day
Pharma site registerMedTech & pharmaData loading
Is your supplier still GMP-certified? One answer per site, with the source.
EU inspectors publish every GMP certificate, licence and non-compliance statement in EudraGMDP, one site at a time. We read all of it every week, join it to FDA inspections and warning letters, and tell you when a site you buy from changes.
For: Pharma QA and sourcing teams qualifying API and finished-dose suppliers.
| Site | Country | Documents listed | Non-compliance | Status |
|---|---|---|---|---|
| Manufacturing site (name withheld) | IN | GMP | issued 2020-02-13 (inspection ended 2019-10-16) | GMP non-compliance in force |
- 36,630
- sites in EudraGMDP (as of 2026-10-25)
- 84
- GMP statements of non-compliance in force
- 1,455
- FDA drug warning letters since 2021
What you get
- GMP and GDP certificates, MIA / WDA licences and API registrations per site
- GMP statements of non-compliance in force or lifted
- FDA inspection classifications and warning letters, matched with a confidence
- Weekly change alerts for your supplier sites
- Per site
- EMA OMS organisation and location ids, name, address, country; valid GMP and GDP certificates (number, issuing authority, issue date), manufacturing / import (MIA) and wholesale (WDA) authorisations, active-substance registrations, GMP statements of non-compliance in force or lifted
- FDA
- Inspection classifications (NAI / VAI / OAI) matched by company name and country, and drug warning letters matched by company name, each with its match confidence and the link to the letter
- Company
- Website domain and registry id of the site organisation where its legal name matches a register entry or an EU medical-device manufacturer, with the method and confidence
- Changes
- New and withdrawn certificates and licences, new and lifted non-compliance statements, FDA OAI results and warning letters, dated by the source. Supplier Watch ranks them next to insolvency and VAT findings
- Privacy
- Organisations only. Qualified persons, responsible persons, inspectors and authority contacts are never read; a site whose name reads as a person (a pharmacist’s own pharmacy) is left out
- Delivery
GET /v1/pharma/sites?domain=&status=,GET /v1/pharma/sites/{id}, the MCP toolpharma_site_check, weekly alerts through Supplier Watch and a licence for the full register file
Pricing
Device Watch 50
€79 / month
- up to 50 companies
- pharma preset: GMP, licence and FDA changes, weekly alert
- €790 / year
Device Watch 250
€199 / month
- up to 250 companies
- pharma preset: GMP, licence and FDA changes, weekly alert
- €1,990 / year
Device Watch Unlimited
€399 / month
- unlimited companies (fair use)
- pharma preset: GMP, licence and FDA changes, weekly alert
- €3,990 / year
Register licence
from €12,000 / year
- every site, document and statement
- weekly delta file
- company join included
The supplier watchlist is the pharma preset of Device Watch: same tiers, same account. Enterprise GMP-intelligence platforms sell at about USD 24,000 to 212,000 a year (Vendr deal data); raw EudraGMDP tables are sold only inside data-library subscriptions. A row is the status the authority published on the date shown, not a finding about a company. Prices without VAT.
Questions
How often is the register read?
Every week, in full. Changes are dated by the source document, not by our read.
Is a row a finding about a company?
No. A row is the status the authority published on the date shown. Read it as status per EudraGMDP on that date.
Do you store qualified persons or inspectors?
No. Organisations only: qualified persons, responsible persons, inspectors and authority contacts are never read.
Sources
- EMA EudraGMDP
- US FDA inspection classifications and warning letters
Official public sources, read without logging in. Companies only, no personal data.